AstraZeneca says COVID-19 vaccine trial in U.S still on hold

Reuters

Published Sep 19, 2020 22:38

(Reuters) - AstraZeneca Plc (L:AZN) said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.